Resources for qualified lymphoedema practitioners

Practitioners undertaking training courses with ALERT can access the following list of resources, provided by companies, charities and professional organisations.

Resources

These resources are external and are not endorsed by ALERT.

The International Lymphoedema Framework is a charity that produces some helpful publications on lymphoedema.

Relevant position statements for the ILF are outlined below.

The peak professional body for lymphology in Australia and New Zealand is the Australasian Lymphology Association (ALA).

The following resources may be helpful if you are establishing a lymphoedema service.

Resources are available for recording circumferential measures of lymphoedema.

The following resources may be helpful.

The following resources may be helpful:

Below you will find a video resources from past ALERT Education events.

ALERT Symposium

  • Date: 27 March 2023
  • Invited speaker: A/Prof Louise Koelmeyer, Director, ALERT Program; Jayne Eagleton, ALERT patient; A/Prof Thomas Lam,  Plastic Surgeon  and Dr Debbie Geyer,  GP and Vice President of the Lymphoedema  Australia Association

ALERT Webinar - Breast Cancer Rehabilitation: The importance of being early and ALERT!

  • Date: 28 March 2023
  • Invited speaker: Dr Negin Sedaghat, Breast Surgeon & Surgical Oncologist; Dr Stephanie Lam, Rehabilitation Medical Physician and Fiona Tisdall Blake, ALERT Lymphoedema Therapist

LE&RN Online Symposium Series - Implementing translational best practice models of care

  • Date: 1 March 2023
  • Invited speaker: A/Prof Louise Koelmeyer, ALERT Director

ALERT Webinar - Managing lymphoedema: Latest research to improve outcomes

  • Date: 22 March 2022
  • Host: Robbie Blackwell, Lymphoedema Therapist
  • Invited speakers: Dr Louise Koelmeyer, ALERT Director and Brenda Gutierrez, Lymphoedema Therapist

ALERT Webinar - Personalising oedema management: Lymphoedema, lipedema and chronic oedema

  • Date: 21 June 2021
  • Host: Dr Louise Koelmeyer, ALERT Director
  • Invited speakers: Dr Louise Koelmeyer, Rebecca Van Gelderen, Dr Helen Mackie, Asha Heydon-White and Kim Toyer
ALERT Webinar - Personalising lymphoedema management using ICG-guided manual lymphatic drainage
  • Date: Tuesday, 13 October 2020
  • Host: Fiona Tisdall Blake, Lymphoedema Therapist
  • Invited speakers: Dr Belinda Thompson, ALERT Postdoctoral Research Fellow and Louise Koelmeyer, ALERT Director
Prevent lymphoedema trial
  • Date: Wednesday, 7 August, 2019
  • Chairperson: Ms Louise Koelmeyer, Acting Director, ALERT
  • Special guest: Dr Sheila Ridner, Martha Rivers Ingram Professor of Nursing at VUSN.

Dr Ridner is the Principal Investigator of the Vanderbilt University Lymphoedema Early Detection Clinical Trial known as 'Prevent', in which Macquarie University is the only participating university outside the US. We have contributed the highest number of trial subjects (450) to the total cohort of 1100 women.

Dr Ridner gave two presentations:

Dr Ridner's presentations were followed by a panel of lymphoedema experts, Dr Sheila Ridner, Dr Helen Mackie and Ms Fiona Tisdall Blake, PT and Lymphoedema Therapist.

Cellulitis in lymphoedema
  • Date: Wednesday, 5 December 2018
  • Chairperson: Ms Louise Koelmeyer, Lymphoedema Program Manager, ALERT
  • Special guest: Professor Vaughan Keeley

Professor Vaughan Keeley is a Consultant Physician who works full-time in lymphoedema. He leads the lymphoedema service in Derby, Nottingham and Mansfield in the UK. Vaughan chairs the British Lymphology Society/Lymphoedema Support Network consensus group, which has produced guidelines on the management of cellulitis in lymphoedema.

Second Harvard Symposium on Lymphoedema in Boston
  • Date: 2–3 November 2018

In November 2018, ALERT Director Prof John Boyages AM and Associate Professor Hiroo Suami attended the second Harvard Symposium on Lymphoedema in Boston as invited speakers. These are their presentations:

Lymphoedema Early Detection Clinical Trial known as 'Prevent'
  • Date: Wednesday, 12 September 2018
  • Chairperson: Professor John Boyages, AM
  • Special guest: Dr Sheila Ridner, Martha Rivers Ingram Professor of Nursing at VUSN.

Dr. Ridner is the Principal Investigator of the Vanderbilt University Lymphoedema Early Detection Clinical Trial known as 'Prevent', in which Macquarie University is the only participating university outside the US. We have contributed the highest number of trial subjects (450) to the total cohort of 1100 women.

Dr Ridner gave three presentations:

The evening also featured a presentation by Ms Louise Koelmeyer giving an update on her research:

Page owner

E: Lymphoedema Clinic